ALPS Medical Breakthroughs ETF
SBIO
38 hedge funds and large institutions have $47.8M invested in ALPS Medical Breakthroughs ETF in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 37 → 38 (+1)
1.89% more ownership
Funds ownership: 44.53% → 46.42% (+1.9%)
7% less capital invested
Capital invested by funds: $51.3M → $47.8M (-$3.49M)
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$1.49M |
| 2 |
RI
Ridgewood Investments
Springfield,
New Jersey
|
+$673K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$626K |
| 4 |
GAM
Griffin Asset Management
New York
|
+$503K |
| 5 |
LPL Financial
San Diego,
California
|
+$295K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.64M |
| 2 |
Morgan Stanley
New York
|
-$881K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$680K |
| 4 |
GS
GTS Securities
New York
|
-$327K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$89.2K |
SBIO Hedge Fund Activity: Q2 2024 in Review
38 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2024, worth a combined $47.8M — down 6.8% from $51.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SBIO positions and 5 closed out — a net gain of 1 holder — while 7 added to existing stakes and 13 trimmed.
The largest buyer was Wells Fargo, adding an estimated $1.49M. The largest seller was Bank of America, cutting an estimated $1.64M.
- 38 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2024, up from 37 in Q1 2024.
- Funds reported $47.8M of ALPS Medical Breakthroughs ETF stock for Q2 2024, down 6.8% quarter-over-quarter.
- 6 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2024 and 5 closed out, a net change of +1 holder.
- The largest ALPS Medical Breakthroughs ETF buyer in Q2 2024 was Wells Fargo, an estimated $1.49M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q2 2024 was Bank of America, an estimated $1.64M sold.
Based on aggregated 13F filings for Q2 2024.